Market Cap 273.16M
Revenue (ttm) 1.45M
Net Income (ttm) -79.28M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -5,467.59%
Debt to Equity Ratio 0.01
Volume 511,200
Avg Vol 1,185,036
Day's Range N/A - N/A
Shares Out 74.23M
Stochastic %K 38%
Beta 1.18
Analysts Strong Sell
Price Target $12.64

Company Profile

Perspective Therapeutics, Inc., together with its subsidiaries, develops and commercializes precision targeted alpha therapies (TAT) to treat cancer in the United States. The company discovers, and develop its initial drug candidate VMT-a-NET that is in Phase 1/2a clinical trials for patients with unresectable or metastatic somatostatin receptor type 2 (SSTR2)-expressing neuroendocrine tumors that have not previously received peptide-targeted radiopharmaceutical therapy, such as Lutathera, a bet...

Industry: Medical Devices
Sector: Healthcare
Phone: 206 676 0900
Address:
2401 Elliott Avenue, Suite 320, Seattle, United States
Alacrity2
Alacrity2 Jul. 4 at 9:53 PM
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 4 at 6:56 AM
0 · Reply
markbass2341
markbass2341 Jul. 3 at 7:30 PM
$CATX oops I’m even
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 3 at 12:26 PM
$CATX https://s3.amazonaws.com/sec.irpass.cc/2508/0000950170-25-093556.htm
1 · Reply
JDinvestments
JDinvestments Jul. 2 at 11:37 PM
$CATX if it drops I will keep adding if it goes up adding as funds available till $5 target $18 plus STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
jto2
jto2 Jul. 2 at 10:12 PM
$CATX July 4th coming up, short week. Longs will enjoy the long weekend— not sure shorts are feeling the same.
1 · Reply
Gurss
Gurss Jul. 2 at 7:22 PM
0 · Reply
JDinvestments
JDinvestments Jul. 2 at 7:09 PM
$CATX load the boat cheapies won’t last forever 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
jto2
jto2 Jul. 2 at 6:01 PM
$CATX If the company plans to sell, I still think it should wait until after Phase 3 and aim for $3B+ valuation. That said, I’m curious how others see it — would you be against 1.5B buyout a $20/share? Honestly, I wouldn’t mind $20 if it happened this year — but I still believe we’re worth much more post–Phase 3.
7 · Reply
wurzelpiet
wurzelpiet Jul. 2 at 4:36 PM
0 · Reply
Latest News on CATX
Perspective Therapeutics: Definitely Not Looking Overvalued Now

Dec 20, 2024, 4:16 PM EST - 7 months ago

Perspective Therapeutics: Definitely Not Looking Overvalued Now


Perspective Therapeutics Inc (CATX) Trading 3.4% Higher on Oct 2

Oct 2, 2024, 12:10 PM EDT - 9 months ago

Perspective Therapeutics Inc (CATX) Trading 3.4% Higher on Oct 2


Alacrity2
Alacrity2 Jul. 4 at 9:53 PM
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 4 at 6:56 AM
0 · Reply
markbass2341
markbass2341 Jul. 3 at 7:30 PM
$CATX oops I’m even
0 · Reply
Xanderzzzzzzz
Xanderzzzzzzz Jul. 3 at 12:26 PM
$CATX https://s3.amazonaws.com/sec.irpass.cc/2508/0000950170-25-093556.htm
1 · Reply
JDinvestments
JDinvestments Jul. 2 at 11:37 PM
$CATX if it drops I will keep adding if it goes up adding as funds available till $5 target $18 plus STRONG BUYOUT 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
jto2
jto2 Jul. 2 at 10:12 PM
$CATX July 4th coming up, short week. Longs will enjoy the long weekend— not sure shorts are feeling the same.
1 · Reply
Gurss
Gurss Jul. 2 at 7:22 PM
0 · Reply
JDinvestments
JDinvestments Jul. 2 at 7:09 PM
$CATX load the boat cheapies won’t last forever 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
jto2
jto2 Jul. 2 at 6:01 PM
$CATX If the company plans to sell, I still think it should wait until after Phase 3 and aim for $3B+ valuation. That said, I’m curious how others see it — would you be against 1.5B buyout a $20/share? Honestly, I wouldn’t mind $20 if it happened this year — but I still believe we’re worth much more post–Phase 3.
7 · Reply
wurzelpiet
wurzelpiet Jul. 2 at 4:36 PM
0 · Reply
Jcljack26
Jcljack26 Jul. 2 at 3:22 PM
$CATX Direction is good but volume is light, lets get some increased volume and get back over $4
0 · Reply
David_M_
David_M_ Jul. 2 at 2:48 PM
0 · Reply
AG80Rider
AG80Rider Jul. 2 at 1:46 PM
$CATX Piper Sandler is focused on mergers and acquisitions... Maybe somethig good is going on?
1 · Reply
AG80Rider
AG80Rider Jul. 2 at 1:45 PM
$CATX https://tipranks.onelink.me/WJho/17c4u7rw
0 · Reply
jto2
jto2 Jul. 2 at 1:27 PM
$CATX Simple and clear about the company you’ve invested in — It targets cancer safely. - Current results show 56% ORR — about 4x better than FDA-approved TAT competitors (10–13%). - Unlike most beta or alpha therapies, it doesn’t harm healthy organs. - Management are commercial-ready.
0 · Reply
morty104
morty104 Jul. 2 at 1:14 PM
$CATX dare o say red open ? Seen it hundreds of times. PM doesn’t mean squat here. It’s probably 100 shares at an inflated price. We’ll see.
0 · Reply
JDinvestments
JDinvestments Jul. 2 at 12:55 PM
$CATX scared yet, not me always adding here VERY UNDERVALUED & BULLISH 💰💰💰🚀🚀🚀🚀🚀🚀
0 · Reply
Gurss
Gurss Jul. 2 at 12:06 PM
0 · Reply
jto2
jto2 Jul. 1 at 11:28 PM
$CATX Seeing posts saying CATX got dropped from “multiple Russell indexes” — but only official FTSE data counts. CATX wasn’t removed from the Russell 3000 and was added to the 2025 Microcap. 3000E isn’t included in FTSE’s official reconstitution announcements — even the original 2024 inclusion PR didn’t mention it. Funny timing for all this noise. But here’s what really matters: strong clinical data, solid cash position, cohort 3 readout expected in 2H, and a potential breakthrough/FDA path. Things look good. added more.
0 · Reply
drdenturedds
drdenturedds Jul. 1 at 11:19 PM
$CATX Well, it doesn't appear like the shorts are not interested in giving up their position just yet. According to fintel.io, the short interest has increased by 130k on the FINRA side of the ledger since 6-27-25 to roughly 480k. The NYSE has yet to report their short interest since 6-13-25, which also increased to 5,616,000 million shares from 5,278,000 just 15 days earlier. So, at some point, they're going to have to cover their position, which will eventually drive the price upwards. On the bright side of things, there are only 400k shares left to short, which limits the investors who want to short the stock going forward. Maybe we'll see some short covering before the end of the week.
1 · Reply
morty104
morty104 Jul. 1 at 8:27 PM
$CATX pos
0 · Reply
Kingtan
Kingtan Jul. 1 at 8:10 PM
$CATX this close is not good technically, we may see ~2,82$
0 · Reply